More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma.
R&D Switzerland at a glance: We are strengthening our local R&D network to contribute to our global strategic goals.
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver our promise to save lives and protect the health of people.
Grow with us: CSL Behring offers university graduates an interesting career as a trainee.
Popular search terms:
2019
News from CSL Behring
Memories and local pride bubble over in Bern, Switzerland, after CSL Behring turns soccer stadium naming rights into a nostal…
The long-standing wish of the fans of Bern soccer club "Young Boys" finally comes true: soon they will see their beloved stad…
They have a chance to play soccer at pro venue.
Not least thanks to the sustainable and environmentally friendly disposal of our waste water, the city of Berne was awarded t…
Janine, Abilashan and Daniel joined CSL Behring in very different ways. In an interview, they tell us what they have already …
At the topping-out ceremony Protinus for the 250 million Swiss francs expansion, CSL Behring thanked the more than 300 constr…
How will we be working in 2030? How will digitalisation, globalisation and resource scarcity impact everyday work? Generation…
With a goal of harnessing academic innovation to bring new therapies to patients with rare and serious diseases around the wo…
CSL Behring AG announces a change of the Site Head in Bern. Pierre Caloz, currently holding the position of Senior Vice Presi…
Americas
Asia Pacific
Middle East
Europe
